ARCHIVES

Drug Approvals; Zykadia Granted Accelerated Approval For ALK+ NSCLC; ADXS-HPV Grated Orphan Drug Designation

This article is from The Cancer Letter archive.

Vol. 40 No. 19 | May 9, 2014

Download PDF Visit The Full Archive

Related Articles

Children of Male Cancer Survivors Have Highrt Risk of Birth Defects

February 25, 2011

Preventive Surgery Cuts Risk Of Breast, Ovarian Cancers

May 31, 2002

Samuel Waksal Resigns From ImClone Following Unimpressive ASCO Presentation

May 24, 2002

Tumor Classification, Monoclonal Antibody Announcements Made

January 7, 1983

In Brief: ACCC Annual Meeting Scheduled March 16-19; Lao to Head Pharmacology At Pittsburgh

January 1, 1988

In Brief: Flood At Ohio’s Arthur James Cancer Hospital Sets Back Opening; Biometry Article Honored

January 19, 1990